11-5947858-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_001003443.3(OR56A3):c.512G>A(p.Arg171His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000589 in 1,614,008 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001003443.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR56A3 | NM_001003443.3 | c.512G>A | p.Arg171His | missense_variant | 3/3 | ENST00000641160.1 | NP_001003443.2 | |
OR56A3 | XM_047426926.1 | c.512G>A | p.Arg171His | missense_variant | 3/6 | XP_047282882.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR56A3 | ENST00000641160.1 | c.512G>A | p.Arg171His | missense_variant | 3/3 | NM_001003443.3 | ENSP00000493059.1 | |||
OR56A3 | ENST00000641905.1 | c.512G>A | p.Arg171His | missense_variant | 4/4 | ENSP00000493319.1 | ||||
OR56A3 | ENST00000641878.1 | n.402-829G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152120Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000196 AC: 49AN: 250164Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135654
GnomAD4 exome AF: 0.0000561 AC: 82AN: 1461888Hom.: 0 Cov.: 36 AF XY: 0.0000440 AC XY: 32AN XY: 727244
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152120Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74296
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 06, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at